Cellectis (CLLS) Long-Term Investments (2023)

Cellectis' Long-Term Investments history runs 12 years deep, the most recent figure standing at $185.7 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 23.81% year-over-year to $185.7 million; the TTM figure through Mar 2026 stood at $185.7 million (down 23.81% YoY), while the FY2025 annual figure was $208.7 million, down 19.84% from the prior year.
• Long-Term Investments for Q1 2026 stood at $185.7 million, down from $208.7 million in the prior quarter.
• The five-year high for Long-Term Investments was $260.3 million in Q4 2024, with the low at $7.7 million in Q3 2024.
• The 5-year median for Long-Term Investments is $35.7 million (2025), against an average of $95.9 million.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments sank 94.73% in 2023, then surged 3214.73% in 2024.
• Cellectis' Long-Term Investments stood at $94.5 million in 2022, then tumbled by 91.69% to $7.9 million in 2023, then soared by 3214.73% to $260.3 million in 2024, then declined by 19.84% to $208.7 million in 2025, then retreated by 11.02% to $185.7 million in 2026.
• Business Quant data shows CLLS's Long-Term Investments at $185.7 million in Q1 2026, $208.7 million in Q4 2025, and $35.7 million in Q3 2025.